TABLE 2.
Baseline characteristics of the subjects who completed the study (n = 26)1
| Value (n = 23 M, 3 F) | |
| Age (y) | 44.3 ± 9.8 (22–65) |
| Weight (kg) | 92.8 ± 18.2 (59.7–137.7) |
| BMI (kg/m2) | 29.0 ± 3.6 (23.7–36.5) |
| SBP (mm Hg) | 122.9 ± 9.5 (98–139) |
| DBP (mm Hg) | 81.9 ± 7.8 (65–96) |
| Lipids and lipoproteins | |
| TG (mg/dL) | 222.8 ± 56.3 (140.5–339) |
| TC (mg/dL) | 206.2 ± 42.3 (133–269) |
| LDL-C (mg/dL) | 121.2 ± 38.1 (57–188.5) |
| HDL-C (mg/dL) | 40.4 ± 8.1 (26–57) |
| Glucose metabolism | 103.5 ± 15.7 (85–163) |
| Glucose (mg/dL) | |
| Insulin (μIU/mL) | 18.0 ± 9.0 (5–40) |
| Markers of inflammation | |
| hs-CRP (mg/L) | 1.26 ± 0.83 (<0.2–2.8) |
| IL-1β (pg/mL) | 0.14 ± 0.09 (0–0.34) |
| IL-6 (pg/mL) | 0.77 ± 0.53 (0.15–2.48) |
| TNF-α (pg/mL) | 1.22 ± 0.30 (0.55–1.71) |
| Liver enzymes (IU/L) | |
| AST | 21.5 ± 5.9 (12–37) |
| ALT | 28.8 ± 12.2 (12–56) |
| Erythrocyte fatty acid content (% by weight) | |
| Eicosapentaenoic acid | 0.49 ± 0.21 (0.21–0.95) |
| Docosapentaenoic acid | 2.68 ± 0.36 (2.00–3.54) |
| Docosahexaenoic acid | 3.97 ± 0.96 (2.32–6.65) |
| Omega-3 index | 4.46 ± 1.13 (2.63–7.45) |
1
All values are means ± SDs; ranges in parentheses. Values were obtained by using the UNIVARIATE procedure (version 9.2; SAS Institute Inc, Cary, NC). Lipids and lipoproteins are the average of 2 samples taken on 2 separate days. LDL-C, LDL cholesterol; HDL-C, HDL cholesterol; TG, triglycerides; TC, total cholesterol; SBP, systolic blood pressure; DBP, diastolic blood pressure; hs-CRP, high-sensitivity C-reactive protein; IL, interleukin; TNF, tumor necrosis factor; AST, aspartate aminotransferase; ALT, alanine aminotransferase.